Page last updated: 2024-08-23

pirfenidone and piperidines

pirfenidone has been researched along with piperidines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Nowak, RA1
Al-Hendy, A; Copland, JA; Young, SL1
Bonella, F; Grunewald, J; Miedema, JR; Spagnolo, P1
Fu, PK; Tseng, CW; Wang, KL; Yen, TH1

Reviews

2 review(s) available for pirfenidone and piperidines

ArticleYear
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
    Seminars in reproductive medicine, 2004, Volume: 22, Issue:2

    Topics: Bexarotene; Female; Heparin; Humans; Interferon-alpha; Leiomyoma; ortho-Aminobenzoates; Piperidines; Pyridones; Quinazolines; Quinazolinones; Reproduction; Tetrahydronaphthalenes; Thiazolidinediones; Tocopherols; Uterine Neoplasms

2004
Looking into the future of sarcoidosis: what is next for treatment?
    Current opinion in pulmonary medicine, 2020, Volume: 26, Issue:5

    Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Biological Products; Cytokines; Dendritic Cells; Fibrosis; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammasomes; Macrophages; Molecular Targeted Therapy; Piperidines; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Sarcoidosis; T-Lymphocytes

2020

Other Studies

2 other study(ies) available for pirfenidone and piperidines

ArticleYear
Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
    Environmental health perspectives, 2000, Volume: 108 Suppl 5

    Topics: Antineoplastic Agents; Blotting, Western; Chromatography, Liquid; Female; Growth Inhibitors; Growth Substances; Humans; Hysterectomy; Hysteroscopy; Immunohistochemistry; Interferon-alpha; Leiomyoma; Phenoxyacetates; Piperidines; Polymers; Protein Synthesis Inhibitors; Pyridones; Quinazolines; Quinazolinones; Receptors, Growth Factor; Uterine Neoplasms

2000
Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report.
    Medicina (Kaunas, Lithuania), 2021, Dec-13, Volume: 57, Issue:12

    Topics: Autoantibodies; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Piperidines; Pyridones; Pyrimidines; Rituximab

2021